Differential chemokine receptor expression and usage by pre-cDC1 and pre-cDC2

Area of Science:

• Immunology
• Cell Biology
• Cancer Research

Background:

• Conventional dendritic cells (cDCs) are crucial immune cells replenished by bone marrow-derived precursors (pre-DCs).
• Pre-DCs are heterogeneous, including pre-cDC1 and pre-cDC2, which differentiate into mature cDC1 and cDC2 subsets.
• Understanding the molecular regulation of pre-DC subset trafficking is vital for immune responses.

Purpose of the Study:

• To elucidate the molecular mechanisms governing the distinct trafficking of pre-cDC1 versus pre-cDC2.
• To investigate the role of chemokine receptors in pre-DC subset homing to peripheral tissues.

Main Methods:

• Flow cytometry and chemokine receptor expression analysis.
• In vivo migration studies in mouse models.
• Pharmacological targeting of CXCR3 regulatory pathways.

Main Results:

• Pre-cDC1, but not pre-cDC2, express the T helper type 1-associated chemokine receptor CXCR3.
• CXCR3 plays a cell-intrinsic role in directing pre-cDC1 migration to melanoma tumors.
• Tumor-infiltrating cDC1 numbers can be enhanced by targeting CD26, a regulator of CXCR3 ligands.

Conclusions:

• Pre-cDC1 and pre-cDC2 exhibit distinct trafficking mechanisms, mediated by CXCR3 expression.
• CXCR3-dependent migration of pre-cDC1 is crucial for tumor infiltration.
• Targeting CD26 offers a potential strategy to augment anti-tumor immunity by increasing cDC1 presence.